Healthcare & Life Sciences Research
Research organizations delivering health economics, outcomes research, and market intelligence for pharmaceutical and healthcare clients.
- 4
- Verticals
Overview
Healthcare & Life Sciences Research firms deliver health economics and outcomes research (HEOR), real-world evidence, and market intelligence for pharmaceutical, biotech, and healthcare clients. It is a specialized, methods-driven research market that supports drug commercialization, payer access, and healthcare strategy — distinct from the laboratory R&D it is sometimes conflated with.
Demand is driven by drug pipelines, payer evidence requirements, and the data needs of pharma commercialization, with major consolidation around real-world-data and analytics platforms (IQVIA and peers). It is a growing, data-asset-driven niche.
Market snapshot
No clean census code — the R&D codes here (541714 biotech, 541715 physical/engineering/life-sciences, together ~$290B) measure laboratory R&D spend, mostly in-house corporate and cross-claimed by the Healthcare and Industrials sectors, not a purchasable research-services business. The HEOR, real-world-evidence, and life-sciences market-intelligence services this segment actually means are a small slice with no code of their own.
Business model & economics
Revenue model
Project research plus recurring real-world-data and analytics subscriptions
Key economics
- Recurring revenue
- Moderate–High
- EBITDA margin
- 18–30%
- Capex intensity
- Low
real-world-data platforms recur
Characteristics
- Methods- and data-driven research, not laboratory R&D.
- Drug pipelines and payer evidence needs drive demand.
- Real-world-data platforms carry the recurring, high-value revenue.
M&A deal context
Who’s acquiring
- Real-world-data & analytics platforms
- Pharma-services consolidators
- PE-backed healthcare-research roll-ups
What’s driving deals
- Consolidation around real-world-data and analytics platforms.
- Pharma commercialization and payer-evidence demand.
- Recurring health-data assets attracting buyers.
Verticals in this segment
Find Healthcare & Life Sciences Research acquisition targets
Search Acquisera’s index for companies classified under Healthcare & Life Sciences Research (1.8.6) and build a targeted deal pipeline.
Search companies